Goldfine; Ira
Patent Applications and Registrations
Patent applications and USPTO patent grants for Goldfine; Ira.The latest application filed is for "antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia".
- Goldfine; Ira - Belvidere CA
- GOLDFINE; Ira - San Francisco CA
| Patent | Date |
|---|---|
| Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia Grant 10,253,101 - Rubin , et al. | 2019-04-09 |
| Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat Hypoglycemia App 20170037135 - Rubin; Paul ; et al. | 2017-02-09 |
| Tyrosine Kinase Receptor Antagonists And Methods Of Treatment For Pancreatic Cancer App 20120214758 - GOLDFINE; Ira ; et al. | 2012-08-23 |
| Tyrosine kinase receptor antagonists and methods of treatment for breast cancer Grant 8,143,226 - Goldfine , et al. March 27, 2 | 2012-03-27 |
| Tyrosine Kinase Receptor Antagonists And Methods Of Treatment For Pancreatic And Breast Cancer App 20070099847 - Goldfine; IRA ; et al. | 2007-05-03 |
| Polymorphic human PC-1 sequences associated with insulin resistance Grant 6,465,185 - Goldfine , et al. October 15, 2 | 2002-10-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 